News

Ideas That Generate Results

APIs are important components of the drug formulations as they responsible for the efficacy of the drugs. The Indian API Domestic Consumption market was valued around US$ 11 Billion in FY 2016. This market is anticipated to reach an approximate value of US$ 19 Billion by 2022. The market will continue its trend of incessant growth owing to factors, such as a rising number of blockbuster drugs expirations resulting in the growth of generics, inauguration of government schemes to promote generic drugs market in India, rapid drug discovery and development process, increasing demand for contract manufacturing, need to reduce API imports from China, stupendous rise in the pharmaceutical market and increasing demand for effective drugs.
 
According to our report, “Indian API Market Outlook 2022”, in the wake of the above developments the Indian API Domestic Consumption industry is expected to grow at a CAGR of around 10% from FY 2016 – FY 2022. The market segmentations have been mentioned in the report. The domestic market, along with the import and export scenario has also been highlighted. Various drivers and challenges have been listed down that affect the API industry in India. Share of India in the Global API market has been mentioned. The government initiatives and regulatory scenario pertaining to API manufacturing and trade has also been discussed in detail. A future opportunity assessment and recommendations have been highlighted to indicate that the Indian API industry has a promising future.
 
The report also covers the key players of the Indian API Market. For every player, a brief business overview and key financials has been provided. A strength and weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of the players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian API market.